Amyotrophic lateral sclerosis (ALS) - Mus musculus (mouse)

Amyotrophic lateral sclerosis (ALS) is a progressive, lethal, degenerative disorder of motor neurons. The hallmark of this disease is the selective death of motor neurons in the brain and spinal cord, leading to paralysis of voluntary muscles. Mutant superoxide dismutase 1 (SOD1), as seen in some familial ALS (FALS) cases, is unstable, forming aggregates in the motor neuron cytoplasm, axoplasm and mitochondria. Within mitochondria, mutant SOD1 may interfere with the anti-apoptotic function of Bcl-2, affect mitochondrial import by interfering with the translocation machinery (TOM/TIM), and generate toxic free radicals (ROS). Reactive oxygen species (ROS), produced within mitochondria, inhibit the function of EAAT2, the main glial glutamate transporter protein, responsible for most of the reuptake of synaptically released glutamate. Glutamate excess increases intracellular calcium, which enhances oxidative stress and mitochondrial damage. Mutant SOD1 can also trigger oxidative reactions , which can then cause damage through the formation of hydroxyl radicals or via nitration of tyrosine residues on proteins. Nitration may target neurofilament proteins, affecting axonal transport. Collectively, these mechanisms are predicted to disturb cellular homeostasis, ultimately triggering motor neuron death.

Human Diseases; Neurodegenerative diseases

Mus musculus (mouse) [GN:mmu]

PMID:16924260

Pasinelli P, Brown RH

Molecular biology of amyotrophic lateral sclerosis: insights from genetics.

Nat Rev Neurosci 7:710-23 (2006)

PMID:16723044

Goodall EF, Morrison KE

Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment.

Expert Rev Mol Med 8:1-22 (2006)

PMID:17015226

Boillee S, Vande Velde C, Cleveland DW

ALS: a disease of motor neurons and their nonneuronal neighbors.

Neuron 52:39-59 (2006)

PMID:11239414

Julien JP.

Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded.

Cell 104:581-91 (2001)

PMID:16050975

Manfredi G, Xu Z

Mitochondrial dysfunction and its role in motor neuron degeneration in ALS.

Mitochondrion 5:77-87 (2005)

PMID:11870681

Hand CK, Rouleau GA

Familial amyotrophic lateral sclerosis.

Muscle Nerve 25:135-59 (2002)

PMID:16713195

Barber SC, Mead RJ, Shaw PJ

Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target.

Biochim Biophys Acta 1762:1051-67 (2006)

PMID:16026864

von Lewinski F, Keller BU

Ca2+, mitochondria and selective motoneuron vulnerability: implications for ALS.

Trends Neurosci 28:494-500 (2005)

PMID:10970056

Al-Chalabi A, Leigh PN

Recent advances in amyotrophic lateral sclerosis.

Curr Opin Neurol 13:397-405 (2000)

PMID:12531867

Guegan C, Przedborski S

Programmed cell death in amyotrophic lateral sclerosis.

J Clin Invest 111:153-61 (2003)

PMID:16909017

Bendotti C, Bao Cutrona M, Cheroni C, Grignaschi G, Lo Coco D, Peviani M, Tortarolo M, Veglianese P, Zennaro E

Inter- and intracellular signaling in amyotrophic lateral sclerosis: role of p38 mitogen-activated protein kinase.

Neurodegener Dis 2:128-34 (2005)

PMID:14739060

Emerit J, Edeas M, Bricaire F

Neurodegenerative diseases and oxidative stress.

Biomed Pharmacother 58:39-46 (2004)

PMID:11715057

Cleveland DW, Rothstein JD

From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS.

Nat Rev Neurosci 2:806-19 (2001)

PMID:15310460

Bendotti C, Carri MT

Lessons from models of SOD1-linked familial ALS.

Trends Mol Med 10:393-400 (2004)

PMID:12595144

Robertson J, Kriz J, Nguyen MD, Julien JP

Pathways to motor neuron degeneration in transgenic mouse models.

Biochimie 84:1151-60 (2002)

PMID:16603792

Bacman SR, Bradley WG, Moraes CT

Mitochondrial involvement in amyotrophic lateral sclerosis: trigger or target?

Mol Neurobiol 33:113-31 (2006)

PMID:18519638

Nishitoh H, Kadowaki H, Nagai A, Maruyama T, Yokota T, Fukutomi H, Noguchi T, Matsuzawa A, Takeda K, Ichijo H

ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1.

Genes Dev 22:1451-64 (2008)

PMID:14569202

Simpson EP, Yen AA, Appel SH

Oxidative Stress: a common denominator in the pathogenesis of amyotrophic lateral sclerosis.

Curr Opin Rheumatol 15:730-6 (2003)

PMID:12728264

Vila M, Przedborski S

Targeting programmed cell death in neurodegenerative diseases.

Nat Rev Neurosci 4:365-75 (2003)

PMID:11513882

Volkel H, Scholz M, Link J, Selzle M, Werner P, Tunnemann R, Jung G, Ludolph AC, Reuter A

Superoxide dismutase mutations of familial amyotrophic lateral sclerosis and the oxidative inactivation of calcineurin.

FEBS Lett 503:201-5 (2001)

PMID:17434459

Eve DJ, Dennis JS, Citron BA

Transcription factor p53 in degenerating spinal cords.

Brain Res 1150:174-81 (2007)

PMID:16909020

Van Damme P, Dewil M, Robberecht W, Van Den Bosch L

Excitotoxicity and amyotrophic lateral sclerosis.

Neurodegener Dis 2:147-59 (2005)

PMID:17566607

Hadano S, Kunita R, Otomo A, Suzuki-Utsunomiya K, Ikeda JE

Molecular and cellular function of ALS2/alsin: implication of membrane dynamics in neuronal development and degeneration.

Neurochem Int 51:74-84 (2007)

PMID:17409386

Kunita R, Otomo A, Mizumura H, Suzuki-Utsunomiya K, Hadano S, Ikeda JE

The Rab5 activator ALS2/alsin acts as a novel Rac1 effector through Rac1-activated endocytosis.

J Biol Chem 282:16599-611 (2007)